177Lu-DOTATATE efficacy and safety in functioning neuroendocrine tumors: A joint analysis of phase II prospective clinical trials

被引：0
|
作者：
Bongiovanni, A. [1 ]
Nicolini, S. [2 ]
Foca, F. [3 ]
Sansovini, M. [2 ]
Grassi, I. [2 ]
Liverani, C. [1 ]
Riva, N. [1 ]
Fausti, V. [1 ]
Mercatali, L. [1 ]
De Vita, A. [1 ]
Fabbri, L. [3 ]
Signoretti, M. [4 ]
Pacilio, C. A. [5 ]
Paganelli, G. [2 ]
Severi, S. [2 ]
Ibrahim, T. [1 ]
Tartaglia, A. [6 ]
机构：
[1] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Osteoncol & Rare Tumor Ctr, Meldola, Italy
[2] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Nucl Med & Radiometabol Unit, Meldola, Italy
[3] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Unit Biostat & Clin Trials, Meldola, Italy
[4] Morgagni Pierantoni Hosp, Unit Gastroenterol & Digest Endoscopy, Forli, Italy
[5] Morgagni Pierantoni Hosp, Gen & Oncol Surg, Forli, Italy
[6] Morgagni Pierantoni Hosp, Unit Endocrinol, Forli, Italy
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1103P
引用
收藏
页码：S912 / S912
页数：1
相关论文
共 50 条
  • [1] 177Lu-DOTATATE efficacy and safety in functioning neuroendocrine tumors: a joint analysis of phase II prospective clinical trials
    Bongiovanni, A.
    Nicolini, S.
    Foca, F.
    Ibrahim, T.
    Sansovini, M.
    Grassi, I.
    Liverani, C.
    Riva, N.
    Bocchini, M.
    Moretti, A.
    Matteucci, F.
    Fabbri, L.
    Signoretti, M.
    Pacilio, C. A.
    Galassi, R.
    Paganelli, G.
    Severi, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S569 - S569
  • [2] 177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials
    Bongiovanni, Alberto
    Nicolini, Silvia
    Ibrahim, Toni
    Foca, Flavia
    Sansovini, Maddalena
    Di Paolo, Arianna
    Grassi, Ilaria
    Liverani, Chiara
    Calabrese, Chiara
    Ranallo, Nicoletta
    Matteucci, Federica
    Paganelli, Giovanni
    Severi, Stefano
    CANCERS, 2022, 14 (24)
  • [3] 177Lu-Dotatate efficacy and safety in functioning neuroendocrine tumors: A joint analysis of phase 2 prospective clinical trials
    Bongiovanni, A.
    Nicolini, S.
    Ibrahim, T.
    Foca, F.
    Sansovini, M.
    Grassi, I
    Liverani, C.
    Fausti, V
    Di Menna, G.
    Maiorano, B. A.
    Paganelli, G.
    Severi, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 175 - 175
  • [4] Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A multicenter study
    Mitjavila Casanovas, M.
    Pubul, V.
    Bello, P.
    Miguel, B.
    Cano, J.
    Balaguer, D.
    Garcia-Burillo, A.
    Marino Mendez, A.
    Rodeno, E.
    Custodio, A.
    Pineiro, A.
    Garcia-Canamaque, L.
    Castellon, M.
    Orduna, M.
    Carmona-Bayonas, A.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S103 - S104
  • [5] Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
    Zidan, Lamiaa
    Iravani, Amir
    Oleinikov, Kira
    Ben-Haim, Simona
    Gross, David J.
    Meirovitz, Amichay
    Maimon, Ophra
    Akhurst, Tim
    Michael, Michael
    Hicks, Rodney J.
    Grozinsky-Glasberg, Simona
    Kong, Grace
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (02) : 218 - 225
  • [6] 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Ozdemir, Nuriye Y.
    Arslan, Suheyla A.
    Sendur, Mehmet A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14): : 1391 - 1391
  • [7] Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine Tumors
    Aljubran, Ali
    Badran, Ahmed
    Alrowaily, Mohamed
    Raef, Hussein
    Alzahrani, Ahmed M.
    Almuhaideb, Ahmed
    Almanea, Hadeel
    El-Dali, Abdelmoneim
    Tuli, Mahmoud
    Bazarbashi, Shouki
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (02) : 164 - 168
  • [8] Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Strosberg, J.
    El-Haddad, G.
    Wolin, E.
    Hendifar, A.
    Yao, J.
    Chasen, B.
    Mittra, E.
    Kunz, P. L.
    Kulke, M. H.
    Jacene, H.
    Bushnell, D.
    O'Dorisio, T. M.
    Baum, R. P.
    Kulkarni, H. R.
    Caplin, M.
    Lebtahi, R.
    Hobday, T.
    Delpassand, E.
    Van Cutsem, E.
    Benson, A.
    Srirajaskanthan, R.
    Pavel, M.
    Mora, J.
    Berlin, J.
    Grande, E.
    Reed, N.
    Seregni, E.
    Oberg, K.
    Sierra, M. Lopera
    Santoro, P.
    Thevenet, T.
    Erion, J. L.
    Ruszniewski, P.
    Kwekkeboom, D.
    Krenning, E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02): : 125 - 135
  • [9] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [10] Functioning neuroendocrine neoplasms: Symptomatic control with 177Lu-DOTATATE
    Lopes-Pinto, M.
    Silva, D.
    Ribeiro, S.
    Oliveira, J.
    Ferreira, G.
    Santos, A. P.
    Torres, I
    Lucena Sampaio, I
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 206 - 206
12345